GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ono Pharmaceutical Co Ltd (OTCPK:OPHLY) » Definitions » E10

Ono Pharmaceutical Co (Ono Pharmaceutical Co) E10 : $0.30 (As of Dec. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Ono Pharmaceutical Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Ono Pharmaceutical Co's adjusted earnings per share data for the three months ended in Dec. 2023 was $0.175. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.30 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Ono Pharmaceutical Co's average E10 Growth Rate was 23.90% per year. During the past 3 years, the average E10 Growth Rate was 19.30% per year. During the past 5 years, the average E10 Growth Rate was 16.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Ono Pharmaceutical Co was 19.30% per year. The lowest was 15.10% per year. And the median was 15.30% per year.

As of today (2024-04-28), Ono Pharmaceutical Co's current stock price is $4.86. Ono Pharmaceutical Co's E10 for the quarter that ended in Dec. 2023 was $0.30. Ono Pharmaceutical Co's Shiller PE Ratio of today is 16.20.

During the past 13 years, the highest Shiller PE Ratio of Ono Pharmaceutical Co was 68.92. The lowest was 17.43. And the median was 35.86.


Ono Pharmaceutical Co E10 Historical Data

The historical data trend for Ono Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ono Pharmaceutical Co E10 Chart

Ono Pharmaceutical Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.17 0.19 0.22 0.23 0.27

Ono Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 0.27 0.26 0.27 0.30

Competitive Comparison of Ono Pharmaceutical Co's E10

For the Drug Manufacturers - General subindustry, Ono Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ono Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ono Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Ono Pharmaceutical Co's Shiller PE Ratio falls into.



Ono Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ono Pharmaceutical Co's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.175/106.8000*106.8000
=0.175

Current CPI (Dec. 2023) = 106.8000.

Ono Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201403 -0.097 95.700 -0.108
201406 0.018 98.000 0.020
201409 0.002 98.500 0.002
201412 0.065 97.900 0.071
201503 -0.068 97.900 -0.074
201506 0.048 98.400 0.052
201509 0.013 98.500 0.014
201512 0.038 98.100 0.041
201603 0.032 97.900 0.035
201606 0.082 98.100 0.089
201609 0.058 98.000 0.063
201612 0.105 98.400 0.114
201703 0.074 98.100 0.081
201706 0.067 98.500 0.073
201709 0.055 98.800 0.059
201712 0.116 99.400 0.125
201803 0.054 99.200 0.058
201806 0.090 99.200 0.097
201809 0.079 99.900 0.084
201812 0.083 99.700 0.089
201903 0.049 99.700 0.052
201906 0.098 99.800 0.105
201909 0.101 100.100 0.108
201912 0.116 100.500 0.123
202003 0.049 100.300 0.052
202006 0.133 99.900 0.142
202009 0.116 99.900 0.124
202012 0.171 99.300 0.184
202103 0.055 99.900 0.059
202106 0.146 99.500 0.157
202109 0.135 100.100 0.144
202112 0.108 100.100 0.115
202203 0.092 101.100 0.097
202206 0.150 101.800 0.157
202209 0.157 103.100 0.163
202212 0.169 104.100 0.173
202303 0.087 104.400 0.089
202306 0.154 105.200 0.156
202309 0.199 106.200 0.200
202312 0.175 106.800 0.175

Add all the adjusted EPS together and divide 10 will get our e10.


Ono Pharmaceutical Co  (OTCPK:OPHLY) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Ono Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=4.86/0.3
=16.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Ono Pharmaceutical Co was 68.92. The lowest was 17.43. And the median was 35.86.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Ono Pharmaceutical Co E10 Related Terms

Thank you for viewing the detailed overview of Ono Pharmaceutical Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Ono Pharmaceutical Co (Ono Pharmaceutical Co) Business Description

Traded in Other Exchanges
Address
8-2, Kyutaromachi 1-chome, Chuo-ku, Osaka, JPN, 541-8564
Ono Pharmaceutical is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. It maintains a global business in specialty pharmaceuticals. The company breaks out its revenue of goods and products into eight segments. The vast majority of Ono's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of Ono's sales are generated in Japan, followed by the rest of Asia and Europe.

Ono Pharmaceutical Co (Ono Pharmaceutical Co) Headlines